In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Redefining Device Innovation--An Interview with John Abele

Executive Summary

Over the past 25 years, few medical device companies have played as large a role in fostering medical device innovation as Boston Scientific. Indeed, through much of the 1980s, Boston Scientific created a new model for a medical device company as technology innovator--one that made the physician less a customer than an ally in the promotion and dissemination of new technology. The visionary behind this new model for device innovation: John Abele, director, founder and chairman at Boston Scientific, who has been a guiding light behind the company's extraordinary technology story--a story that continues today, not just in Boston's dramatic success in drug-eluting stents, but also in the diverse technology portfolio the company has assembled. In the following interview, Abele, whose training was neither in medicine nor engineering, talks about his early days in the medical device industry and the principles that guided him.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV002366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel